• Profile
Close

Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy

Nephrology Jul 03, 2018

Lim CC, et al. - The epidemiology, risk factors and outcomes of cytomegalovirus (CMV) infection were ascertained among patients with glomerulonephritis (GN) who received potent immunosuppressants (IS) via performing a single-centre retrospective study of adults with biopsy-proven GN prescribed methylprednisolone (MP), cyclophosphamide (CYC) or rituximab (RTX). Observations suggested a common prevalence of CMV infection in GN patients receiving potent IS. They recommend considering surveillance and possibly anti-viral prophylaxis for high-risk patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay